Managing _ O
Director _ O
’ _ O
s _ O
Perspective _ O
I _ O
would _ O
like _ O
to _ O
thank _ O
everyone _ O
at _ O
Divi _ O
’ _ O
s _ O
for _ O
their _ O
unwavering _ O
commitment _ O
in _ O
response _ O
to _ O
Covid _ B-key
- _ I-key
19 _ I-key
pandemic _ I-key
and _ O
serve _ O
our _ O
customers _ O
through _ O
these _ O
challenging _ O
times _ O
. _ O

The _ O
resilience _ O
of _ O
our _ O
business _ O
model _ O
will _ O
enable _ O
us _ O
to _ O
emerge _ O
stronger _ O
and _ O
ensure _ O
reliability _ O
in _ O
an _ O
ever-changing _ O
dynamic _ O
world _ O
. _ O

Dear _ O
Shareholders _ B-key
, _ O
The _ O
financial _ O
year _ O
2021 _ O
- _ O
22 _ O
began _ O
on _ O
a _ O
subdued _ O
note _ O
owing _ O
to _ O
repeated _ O
attacks _ O
of _ O
the _ O
pandemic _ B-key
, _ O
taking _ O
a _ O
severe _ O
toll _ O
on _ O
lives _ O
and _ O
economies _ O
. _ O

As _ O
the _ O
world _ O
navigated _ O
through _ O
the _ O
pandemic _ B-key
, _ O
the _ O
escalation _ O
of _ O
geopolitical _ B-key
strife _ I-key
compounded _ O
the _ O
crisis _ O
and _ O
brought _ O
numerous _ O
other _ O
challenges _ O
in _ O
the _ O
form _ O
of _ O
strained _ O
geopolitical _ O
and _ O
trade _ B-key
relations _ I-key
, _ O
a _ O
runaway _ B-key
inflation _ I-key
and _ O
unprecedented _ O
volatility _ O
in _ O
commodity _ B-key
costs _ I-key
. _ O

In _ O
the _ O
face _ O
of _ O
such _ O
flux _ O
, _ O
the _ O
industry _ O
showed _ O
resilience _ O
and _ O
adaptability _ O
, _ O
ensuring _ O
continuous _ B-key
supply _ I-key
of _ O
medicines _ O
to _ O
help _ O
patients _ O
gain _ O
access _ O
to _ O
their _ O
medication _ O
. _ O

The _ O
pandemic _ B-key
has _ O
accelerated _ O
significant _ O
change _ O
in _ O
the _ O
healthcare _ B-key
ecosystem _ I-key
, _ O
making _ O
it _ O
more _ O
adaptable _ O
and _ O
innovative _ O
in _ O
order _ O
to _ O
withstand _ O
unexpected _ O
challenges _ O
and _ O
capitalise _ B-key
on _ O
the _ O
opportunities _ O
. _ O

In _ O
this _ O
uncertain _ O
operating _ O
environment _ O
, _ O
our _ O
focus _ O
remained _ O
on _ O
the _ O
health _ O
and _ O
safety _ O
of _ O
our _ O
people _ O
, _ O
ensuring _ O
uninterrupted _ B-key
supply _ I-key
of _ O
our _ O
products _ O
to _ O
meet _ O
the _ O
evolving _ B-key
demand _ I-key
of _ O
our _ O
customers _ O
and _ O
our _ O
business _ B-key
needs _ I-key
. _ O

This _ O
has _ O
strongly _ O
positioned _ O
us _ O
as _ O
a _ O
reliable _ O
supplier _ O
to _ O
the _ O
global _ O
pharmaceutical _ B-key
companies _ O
. _ O

The _ O
year _ O
in _ O
review _ O
The _ O
year _ O
had _ O
been _ O
challenging _ O
with _ O
several _ O
headwinds _ O
and _ O
against _ O
this _ O
backdrop _ O
, _ O
our _ O
results _ O
for _ O
the _ O
year _ O
demonstrate _ O
our _ O
execution _ O
prowess _ O
, _ O
agility _ O
, _ O
strategic _ O
clarity _ O
and _ O
the _ O
strength _ O
of _ O
supply _ B-key
chain _ I-key
. _ O

Our _ O
core _ O
investment _ B-key
for _ O
the _ O
past _ O
two _ O
years _ O
on _ O
debottlenecking _ O
, _ O
capacity _ O
expansion _ O
and _ O
backward _ O
integration _ O
strength _ O
helped _ O
us _ O
achieve _ O
scale _ O
and _ O
de-risk _ O
external _ O
starting _ O
material _ O
dependence _ O
. _ O

Our _ O
agile _ B-key
business _ I-key
model _ I-key
and _ O
stable _ B-key
supply _ I-key
chain _ I-key
ensured _ O
minimal _ O
business _ O
disruption _ O
and _ O
uninterrupted _ O
supply _ O
to _ O
our _ O
customers _ O
across _ O
the _ O
globe _ O
. _ O

The _ O
commitment _ O
and _ O
determined _ O
efforts _ O
of _ O
the _ O
entire _ O
Divi _ O
’ _ O
s _ O
family _ O
helped _ O
us _ O
live _ O
up _ O
to _ O
the _ O
name _ O
of _ O
a _ O
reliable _ O
supplier _ O
of _ O
API _ O
’ _ O
s _ O
. _ O

As _ O
a _ O
global _ O
leader _ O
of _ O
API _ O
’ _ O
s _ O
, _ O
we _ O
have _ O
always _ O
accommodated _ O
the _ O
sudden _ O
increase _ O
in _ O
market _ B-key
demands _ I-key
quickly _ O
. _ O

We _ O
have _ O
also _ O
sucessfully _ O
completed _ O
the _ O
capacity _ O
expansions _ O
that _ O
we _ O
have _ O
taken _ O
up _ O
during _ O
the _ O
year _ O
. _ O

Keeping _ O
our _ O
Green _ O
commitment _ O
During _ O
the _ O
year _ O
FY2022 _ O
, _ O
apart _ O
from _ O
creating _ O
additional _ O
capacities _ O
for _ O
our _ O
pipeline _ B-key
products _ I-key
and _ O
new _ O
capacities _ O
for _ O
emerging _ O
custom _ O
synthesis _ B-key
projects _ I-key
, _ O
we _ O
have _ O
also _ O
upgraded _ O
our _ O
utility _ B-key
infrastructure _ I-key
, _ O
which _ O
also _ O
includes _ O
environment _ B-key
management _ I-key
. _ O

We _ O
strive _ O
to _ O
create _ O
brand _ B-key
value _ I-key
by _ O
adopting _ O
sustainable _ B-key
practices _ I-key
and _ O
implementing _ O
Green _ O
chemistry _ O
principles _ O
. _ O

As _ O
an _ O
industry _ O
leader _ O
and _ O
a _ O
responsible _ O
enterprise _ O
, _ O
we _ O
served _ O
the _ O
communities _ O
around _ O
our _ O
manufacturing _ O
facilities _ O
in _ O
several _ O
ways _ O
by _ O
enhancing _ O
the _ O
village _ O
infrastructure _ B-key
, _ O
providing _ O
safe _ O
drinking _ O
water _ O
, _ O
empowering _ O
women _ O
and _ O
improving _ O
public _ B-key
healthcare _ I-key
. _ O

Future _ O
focused _ O
– _ O
Agile _ O
, _ O
consistent _ O
and _ O
reliable _ O
As _ O
we _ O
enter _ O
a _ O
new _ O
financial _ O
year _ O
, _ O
we _ O
are _ O
better _ O
prepared _ O
to _ O
handle _ O
the _ O
evolving _ O
demand _ B-key
, _ O
continuous _ O
market _ B-key
volatility _ I-key
and _ O
an _ O
uncertain _ O
economic _ B-key
environment _ I-key
. _ I-key

At _ O
Divi _ O
’ _ O
s _ O
, _ O
we _ O
aim _ O
to _ O
exceed _ O
the _ O
internal _ O
benchmark _ O
so _ O
that _ O
we _ O
can _ O
consistently _ O
deliver _ O
value _ O
to _ O
our _ O
customers _ O
, _ O
and _ O
also _ O
perform _ O
as _ O
a _ O
dependable _ O
supplier _ O
. _ O

Our _ O
focus _ O
will _ O
remain _ O
on _ O
Continuous _ O
process _ O
innovation _ O
and _ O
Green _ O
chemistry _ O
implementation _ O
to _ O
further _ O
establish _ O
Divi's _ O
as _ O
a _ O
strong _ O
sustainable _ B-key
organisation _ I-key
and _ O
deliver _ O
value _ O
added _ O
performance _ O
. _ O

I _ O
would _ O
like _ O
to _ O
take _ O
this _ O
opportunity _ O
and _ O
thank _ O
our _ O
employees _ O
for _ O
their _ O
consistent _ O
effort _ O
to _ O
deliver _ O
the _ O
best _ O
results _ O
despite _ O
the _ O
challenges _ O
. _ O

I _ O
thank _ O
all _ O
the _ O
stakeholders _ O
for _ O
reposing _ O
their _ O
trust _ O
in _ O
us _ O
, _ O
which _ O
has _ O
made _ O
Divi _ O
’ _ O
s _ O
a _ O
reliable _ B-key
brand _ I-key
. _ O

We _ O
will _ O
continue _ O
to _ O
strive _ O
for _ O
leadership _ O
through _ O
chemistry _ O
and _ O
be _ O
the _ O
most _ O
reliable _ O
supplier _ O
of _ O
high-quality _ O
API _ O
’ _ O
s _ O
while _ O
creating _ O
value _ O
for _ O
all _ O
our _ O
stake _ O
holders _ O
. _ O

Dr _ O
. _ O

Murali _ O
K _ O
. _ O

Divi _ O
Managing _ O
Director _ O
Production _ O
Blocks _ O
- _ O
Exterior _ O
View _ O
2 _ O
332nd _ O
Annual _ O
Report _ O
2021 _ O
- _ O
22 _ O
Corporate _ O
Overview _ O

